Chitogenx Stock EBITDA
| CHNXF Stock | USD 0.01 0.0001 1.96% |
ChitogenX fundamentals help investors to digest information that contributes to ChitogenX's financial success or failures. It also enables traders to predict the movement of ChitogenX OTC Stock. The fundamental analysis module provides a way to measure ChitogenX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChitogenX otc stock.
ChitogenX |
ChitogenX OTC Stock EBITDA Analysis
ChitogenX's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current ChitogenX EBITDA | (3.72 M) |
Most of ChitogenX's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChitogenX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, ChitogenX reported earnings before interest,tax, depreciation and amortization of (3.72 Million). This is 100.42% lower than that of the Healthcare sector and 103.71% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.1% higher than that of the company.
ChitogenX EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChitogenX's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of ChitogenX could also be used in its relative valuation, which is a method of valuing ChitogenX by comparing valuation metrics of similar companies.ChitogenX is currently under evaluation in ebitda category among its peers.
ChitogenX Fundamentals
| Return On Asset | -2.92 | |||
| Current Valuation | 12.49 M | |||
| Shares Outstanding | 51.04 M | |||
| Shares Owned By Insiders | 17.44 % | |||
| EBITDA | (3.72 M) | |||
| Net Income | (4.92 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 4.78 M | |||
| Current Ratio | 1.26 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (3.22 M) | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.86 M | |||
| Total Asset | 1.12 M | |||
| Z Score | -8.7 | |||
| Net Asset | 1.12 M |
About ChitogenX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChitogenX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChitogenX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChitogenX based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.